Medical News

Gene Therapy Study Produces Promising Results for Patients with Hemophilia B

September 19, 2013

A fraction of patients with a common form of the bleeding disorder hemophilia develop an allergic reaction to the blood-clotting treatment they need to keep them alive. But using gene therapy, University of Florida researchers were able to reverse this reaction and provide long-lasting treatment for the disease in an animal model, according to findings […]

Federal Data System for Obamacare Exchanges Gets Security OK

September 13, 2013

(Reuters) – The data system supporting President Barack Obama’s healthcare reform has been tested and certified as secure for millions of Americans who will seek health coverage beginning on October 1, meeting a critical deadline for launching the program, the administration said on Wednesday. Concerns over whether consumer information would be secure in time were […]

Hepatitis C: Our History and Advances on the Horizon

August 8, 2013

Recognizing National Hepatitis Awareness Month The month of May is recognized to bring awareness around those living with viral hepatitis. The awareness effort encourages people to get tested for hepatitis and to evaluate treatment options. According to the Centers for Disease Control and Prevention (CDC), an estimated 3.2 million people in the U.S. with chronic […]

NY Times: After Marrow Transplants, 2 More Patients Appear HIV-Free Without Drugs

July 3, 2013

By DONALD G. McNEIL Jr. Two H.I.V.-infected patients in Boston who had bone-marrow transplants for blood cancers have apparently been virus-free for weeks since their antiretroviral drugs were stopped, researchers at an international AIDS conference announced Wednesday. The patients鈥 success echoes that of Timothy Ray Brown, the famous 鈥淏erlin patient,鈥 who has shown no signs […]

Supreme Court Says Isolated Human Genes Cannot Be Patented

June 13, 2013

WASHINGTON (AP) 鈥 The Supreme Court ruled Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries. The high court鈥檚 unanimous judgment reverses three decades of patent awards by government officials. It throws out patents held by Salt Lake […]

FDA Rejects Two Gilead HIV Drugs as Standalone Products

April 29, 2013

Washington (Reuters) – Gilead Sciences Inc said on Monday that U.S. health rejected two of its HIV drugs as standalone therapies, citing deficiencies in documentation and validation of certain quality testing procedures. Gilead said it is working with U.S. Food and Drug Administration to address the questions raised in the rejection letter in order to […]

Life Sciences Firm Entegrion Lands Global Partner

April 1, 2013

Research Triangle Park, N.C. 鈥 Blood technologies company Entegrion is partnering with an Italian company to develop and commercialize Resusix, Entegrion鈥檚 freeze-dried human plasma. Under the deal, Kedrion Melville gains exclusive worldwide rights to commercialize Resusix. Entegrion, based in Research Triangle Park, will collaborate with Kedrion on clinical development of the product. Clinical trials are […]

New CDC Division of Blood Disorders Director

April 1, 2013

Dr. Lisa Richardson will be joining the Division of Blood Disorders as the Division Director on April 8, 2013. Dr. Lisa C. Richardson is a medical officer at the Centers for Disease Control and Prevention in Atlanta, Georgia. Dr. Richardson most recently served as the Associate Director of Science in the Division of Cancer Prevention […]

FDA Accepts Biogen Idec鈥檚 License Application for First Long-Lasting Factor Therapy for Hemophilia B

March 4, 2013

WESTON, Mass.-Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) has accepted the company`s Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline. Recombinant FIXFc is the first product candidate in […]

CNN: Researchers Say Toddler Cured of HIV

March 4, 2013

(CNN) — It’s a potential game changer in the fight against HIV, and doctors say it happened almost by accident. A baby with the virus that causes AIDS was given high doses of three antiretroviral drugs within 30 hours of her birth. Doctors knew the mother was HIV positive and administered the drugs in hopes […]

White House Petition: Help Save Lives of Millions With Hepatitis C

February 18, 2013

Dear Friends, We need your help in order to get this cure for Hepatitis C. 路 Over 170 million people worldwide have Hepatitis C (HCV) 路 Hepatitis C now kills more people than AIDS 路 Hepatitis C is now the leading reason for liver transplants The cure was developed by two drug companies together, but […]

Gilead Sciences Petition: Stop Withholding This Cure for Hepatitis C

February 14, 2013

TO: Supporters and Friends of People with Bleeding Disorders and HCV: Previously we described the situation in which Gilead Sciences, a drug development firm, likely found a cure …. and walked away from it, solely for the business reasons.聽 Explanation: they own only half of the successful drug combination and they don鈥檛 want to split […]

Hemophilia Association of NY Request Proposals for Research Grants

February 7, 2013

Bleeding Disorders FVIII Research, excluding inhibitors research Proposals should involve laboratory scientist/clinician collaboration and may be multi-institutional. Designed to facilitate an eventual clinical trial. If at that time the project is ready for clinical trial, further funding may be available to support that trial. ELIGIBILITY: Applicants must hold an M.D., Ph.D. or equivalent degree and […]

New England Journal of Medicine:Inhibitor Development in Severe Hemophilia A Patients

January 18, 2013

NEJM Article,聽Factor VIII Products and Inhibitor Development in Severe Hemophilia A BACKGROUND For previously untreated children with severe hemophilia A, it is unclear whether the type of factor VIII product administered and switching among products are associated with the development of clinically relevant inhibitory antibodies (inhibitor development). METHODS We evaluated 574 consecutive patients with severe […]

FDA: Metal-on-Metal Hip Implants: Safety Communication – Updated Safety Recommendations

January 17, 2013

AUDIENCE: Orthopaedic surgery, Radiology, Risk Manager ISSUE: FDA notified healthcare professionals that it is providing updated safety information and recommendations to patients and health care providers, based on the FDA’s current assessment of metal-on-metal hip implants, including the benefits and risks, the evaluation of the published literature, and the results of the June 2012 Orthopaedic […]

Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek Combination Treatment): Drug Safety Communication – Serious Skin Reactions

December 19, 2012

AUDIENCE: Internal Medicine, Gastroenterology, Dermatology ISSUE: FDA received reports of serious skin reactions, some fatal, in patients taking the hepatitis C drug Incivek (telaprevir) in combination with the drugs peginterferon alfa and ribavirin (Incivek combination treatment). Some patients died when they continued to receive Incivek combination treatment after developing a worsening, or progressive rash and […]

Acupuncture: Needles & Hemophilia? Does This Make Sense?

December 6, 2012

Hemophilia pain It is well known that persons with hemophilia have episodes of painful experiences. Pain results after an acute joint bleed, where the synovial capsule fills with blood and expands with nowhere to go. Once the bleeding is treated with factor,with time the blood in the joint is reabsorbed and the swelling and pain […]

Novo Nordisk announces U.S. results of largest multinational psychosocial study of living with hemophilia

November 7, 2012

Orlando, Fla. – U.S. patient and caregiver results derived from the largest multinational psychosocial study of the hemophilia community are being presented at the National Hemophilia Foundation (NHF) 64th Annual Meeting. In total, four posters were accepted from the Hemophilia Experiences, Results and Opportunities (HERO) study, a comprehensive analysis of the experience of living with […]

U-M Registers Six New Embryonic Stem Cell Lines

June 14, 2012

Source:聽Detroit News聽聽By: Kim Kozlowski The genetic mutation responsible for a blood clotting disorder known as hemophilia B is among two embryonic stem cell lines created by the University of Michigan and believed to be the first in the world to carry the disease, officials announced Thursday. The two stem cell lines are among six new […]

HFA Observes National Hepatitis Awareness Month

May 3, 2012

HFA Observes National聽Hepatitis聽Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo (202)-675-6984聽 Link to PDF of HFA Celebrates Hepatitis Awareness Month Washington, D.C. – In 2001, the Centers for Disease Control (CDC) and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral […]

HFA Observes National Hepatitis Awareness Month

May 3, 2012

HFA Observes National聽Hepatitis聽Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo (202)-675-6984聽 Link to PDF of HFA Celebrates Hepatitis Awareness Month Washington, D.C. – In 2001, the Centers for Disease Control (CDC) and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral […]

New England Journal of Medicine Publishes Results of Study on Anti-Inhibitor Coagulant Prophylaxis in Hemophilia Patients with Inhibitors

November 4, 2011

The following is an excerpt from an article published in the New England Journal of Medicine. Read the full article here. Summary After exposure to factor VIII, alloantibodies (inhibitors) that neutralize factor VIII clotting function develop in approximately 30% of patients with severe hemophilia A.1 The development of high-titer factor VIII inhibitors (>5 Bethesda units […]

Advisory Panel Releases ‘Essential Benefits’ Report

October 7, 2011

The聽Institute聽of Medicine (IOM) released its report of recommendations to the United States Department of Health and Human Services regarding what health benefits should 聽be provided by insurance plans under the Health reform law – the Affordable Care Act (ACA). 聽 The ACA requires states to set up an health insurance market place or exchange by […]

So Far, Exchanges Are a ‘Mixed Bag’ for Patients, Group Says

July 6, 2011

By John Reichard, CQ HealthBeat Editor The health care law will disappoint many Americans if its health insurance exchanges don’t deliver decent coverage at affordable rates for consumers, including those with serious illnesses like cancer. Meeting those expectations may be difficult, judging from comments by a major patient advocacy group as it waits for the […]

Living With Hepatitis C

July 1, 2011

Mark Antell talks candidly about his hemophilia and hepatitis C.

Viral Outbreaks in Dogs Yield Clues on Origins of Hepatitis C

May 31, 2011

New York Times article link By CARL ZIMMER Published: May 30, 2011 Hepatitis C is, in some ways, a high-profile disease. Worldwide, an estimated 200 million people are infected with the virus. Some of them will suffer cirrhosis, liver cancer and even death. Celebrities like Steven Tyler of Aerosmith and “American Idol” have spoken publicly […]

Merck’s Hepatitis C Drug Wins F.D.A. Approval

May 16, 2011

Click here for New York Times article. By ANDREW POLLACK Published: May 13, 2011 The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more […]

Valeant, Kadmon sign deals on hepatitis C drugs

November 2, 2010

Link to article Mon Nov 1, 2010 11:01am EDT TORONTO (Reuters) – Canada’s Valeant Pharmaceuticals International (VRX.TO: Quote) and U.S. company Kadmon Pharmaceuticals said on Monday they have signed two deals to partner on hepatitis C drugs as Valeant moves to end development of antiviral drugs but seeks to bolster its offering of already commercialized […]

WebMD: “New Hepatitis C Drugs in the Works”

October 15, 2010

Click here for full article Hepatitis Health Center New Hepatitis C Drugs in the Works Study Show 2 Experimental Drugs Are Able to Reduce Virus Levels in Blood By Salynn Boyles WebMD Health News Reviewed by Laura J. Martin, MD Oct. 14, 2010 — The long wait for new drugs that cure hepatitis C virus […]

May is National Hepatitis Month

May 10, 2010

May is National Hepatitis Month Earlier this year the Institute of Medicine (IOM) released a report on Viral Hepatitis in the United States and called for efforts to increase knowledge and awareness of this major public health problem. During the month of May, CDC and our public health partners are celebrating the 15th anniversary of […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.